Literature DB >> 22971247

Modifying risk factors to prevent and treat erectile dysfunction.

Sidney Glina1, Ira D Sharlip, Wayne J G Hellstrom.   

Abstract

INTRODUCTION: Erectile dysfunction (ED) is a common complaint in men over 40 years of age and prevalence rates increase with age. Comorbidities such as heart disease, diabetes, dyslipidemia, hypertension, and depression have been described as primary risk factors for the development of ED. Additionally, a number of modifiable lifestyle factors, including physical activity, smoking, alcohol consumption, diabetes control, and obesity, have been associated with ED. AIM: The association of modifiable behavioral factors with ED, mainly among men without recognized comorbidities, opens the possibility for intervention strategies to prevent and potentially improve erectile function in patients suffering with ED.
CONCLUSION: While intriguing, most of the literature and evidence is not completely scientifically compelling as to how modifying lifestyle risk factors can improve erectile function. Weight loss may reverse ED through other mechanisms, namely, decreased inflammation, increased serum testosterone levels, and improved mood and self-esteem. Currently, the evidence at hand recommends that patient education should be aimed at increasing exercise, reducing weight to achieve a body mass index less than 30 kg/m(2), and stopping smoking to improve or restore erectile function, mainly in men without established comorbidities. When comorbidities are present, lifestyle modifications may be important in preventing or reducing sexual dysfunction. These modifications may include precise glycemic control in diabetic men and the use of pharmacologic therapies for hypertension and depression, which are less likely to cause sexual side effects.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22971247     DOI: 10.1111/j.1743-6109.2012.02816.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  12 in total

1.  Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction.

Authors:  Aviva E Weinberg; Michael Eisenberg; Chirag J Patel; Glenn M Chertow; John T Leppert
Journal:  J Sex Med       Date:  2013-09-09       Impact factor: 3.802

2.  Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.

Authors:  Darshan P Patel; Jeannette M Schenk; Amy Darke; Jeremy B Myers; William O Brant; James M Hotaling
Journal:  BJU Int       Date:  2015-09-20       Impact factor: 5.588

3.  Exercise prevents Western diet-associated erectile dysfunction and coronary artery endothelial dysfunction: response to acute apocynin and sepiapterin treatment.

Authors:  Justin D La Favor; Ethan J Anderson; Jillian T Dawkins; Robert C Hickner; Christopher J Wingard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-12       Impact factor: 3.619

4.  Modifiable risk factors for erectile dysfunction: an assessment of the awareness of such factors in patients suffering from ischaemic heart disease.

Authors:  D Kałka; Z Domagała; A Rakowska; K Womperski; R Franke; E Sylwina-Krauz; J Stanisz; M Piłot; J Gebala; L Rusiecki; W Pilecki
Journal:  Int J Impot Res       Date:  2015-12-03       Impact factor: 2.896

5.  Immunization associated with erectile dysfunction based on cross-sectional and genetic analyses.

Authors:  Yang Chen; Xianxiang Xin; Haiying Zhang; Jianfeng Xu; Yong Gao; Aihua Tan; Xiaobo Yang; Xue Qin; Yanling Hu; Zengnan Mo
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

6.  Long-term treatment of clonidine, atenolol, amlodipine and dihydrochlorothiazide, but not enalapril, impairs the sexual function in male spontaneously hypertensive rats.

Authors:  Li-Li Lin; Dong Wang; Wei Wang; Yan-Qiong Cheng; Ding-Feng Su; Ai-Jun Liu
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

7.  Depressive symptoms in patients diagnosed with benign prostatic hyperplasia.

Authors:  Barbara Pietrzyk; Magdalena Olszanecka-Glinianowicz; Aleksander Owczarek; Tomasz Gabryelewicz; Agnieszka Almgren-Rachtan; Andrzej Prajsner; Jerzy Chudek
Journal:  Int Urol Nephrol       Date:  2015-02-12       Impact factor: 2.370

Review 8.  Association of endothelial nitric oxide synthase polymorphisms with an increased risk of erectile dysfunction.

Authors:  Lei Gao; Zhifeng Zhao; Fengfu Guo; Yan Liu; Jianhua Guo; Yang Zhao; Zhong Wang
Journal:  Asian J Androl       Date:  2017 May-Jun       Impact factor: 3.285

Review 9.  Sexual dysfunction in 2013: Advances in epidemiology, diagnosis and treatment.

Authors:  King Chien Joe Lee; Nader Fahmy; Gerald B Brock
Journal:  Arab J Urol       Date:  2013-07-23

10.  Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases.

Authors:  Gerald Brock; Xiao Ni; Matthias Oelke; John Mulhall; Matt Rosenberg; Allen Seftel; Deborah D'Souza; Jane Barry
Journal:  J Sex Med       Date:  2016-05       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.